Market Research Logo

Wound Closure Hemostats - Medical Devices Pipeline Assessment, 2017

Wound Closure Hemostats - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Wound Closure Hemostats - Medical Devices Pipeline Assessment, 2017 provides an overview of Wound Closure Hemostats currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Hemostats pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

  • Extensive coverage of the Wound Closure Hemostats under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Hemostats and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Hemostats under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Wound Closure Hemostats Overview
  • Products under Development
    • Wound Closure Hemostats - Pipeline Products by Stage of under Development
      • Table Figure 1: Wound Closure Hemostats - Pipeline Products by Stage of under Development
      • Table Wound Closure Hemostats - Pipeline Products by Stage of under Development
    • Wound Closure Hemostats - Pipeline Products by Segment
      • Table Figure 2: Wound Closure Hemostats - Pipeline Products by Segment Pipeline Products by Segment
      • Table Wound Closure Hemostats - Pipeline Products by Segment
    • Wound Closure Hemostats - Pipeline Products by Territory
      • Table Figure 3: Wound Closure Hemostats - Pipeline Products by Territory
      • Table Wound Closure Hemostats - Pipeline Products by Territory
    • Wound Closure Hemostats - Pipeline Products by Regulatory Path
      • Table Figure 4: Wound Closure Hemostats - Pipeline Products by Regulatory Path
      • Table Wound Closure Hemostats - Pipeline Products by Regulatory Path
    • Wound Closure Hemostats - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Wound Closure Hemostats - Pipeline Products by Estimated Approval Date
      • Table Wound Closure Hemostats - Pipeline Products by Estimated Approval Date
    • Wound Closure Hemostats - Ongoing Clinical Trials
      • Table Figure 6: Wound Closure Hemostats - Ongoing Clinical Trials
      • Table Wound Closure Hemostats - Ongoing Clinical Trials
  • Wound Closure Hemostats - Pipeline Products under Development by Companies
    • Wound Closure Hemostats Companies - Pipeline Products by Stage of Development
      • Table Hemostats Companies - Pipeline Products by Stage of Development
    • Wound Closure Hemostats - Pipeline Products by Stage of Development
      • Table Hemostats - Pipeline Products by Stage of Development
  • Wound Closure Hemostats Companies and Product Overview
    • 3-D Matrix Ltd Company Overview
      • 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PuraStat Hemostat - Product Status
        • Table PuraStat Hemostat - Product Description
        • Table TDM-511 - Product Status
        • Table TDM-511 - Product Description
        • Table 3-D Matrix Ltd - Ongoing Clinical Trials Overview
        • Table PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery
        • Table PuraStat Hemostat - Randomized Controlled Trial Comparing Purastat to Standard Therapy for Haemostasis Control During Endoscopic Submucosal Dissection
    • Anika Therapeutics Inc Company Overview
      • Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Patch - Product Status
        • Table Hemostatic Patch - Product Description
    • Arch Therapeutics Inc Company Overview
      • Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AC5 Surgical Hemostatic Device - Product Status
        • Table AC5 Surgical Hemostatic Device - Product Description
        • Table AC5 Surgical Hemostatic Device - Internal Use - Product Status
        • Table AC5 Surgical Hemostatic Device - Internal Use - Product Description
    • Argon Medical Devices Inc Company Overview
      • Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemaseel Thrombin Haemostatic Agent - Product Status
        • Table Hemaseel Thrombin Haemostatic Agent - Product Description
    • Baxter International Inc Company Overview
      • Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemopatch - Product Status
        • Table Hemopatch - Product Description
        • Table Baxter International Inc - Ongoing Clinical Trials Overview
        • Table Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)
        • Table Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant
        • Table Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection
        • Table Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial
        • Table Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH
    • Beth Israel Deaconess Medical Center Inc Company Overview
      • Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portable Wound Hemostasis System - Product Status
        • Table Portable Wound Hemostasis System - Product Description
    • Biomedica Management Corp Company Overview
      • Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClotFoam - Product Status
        • Table ClotFoam - Product Description
        • Table ClotGel - Product Status
        • Table ClotGel - Product Description
        • Table ClotSpray - Product Status
        • Table ClotSpray - Product Description
    • Biom'Up SAS Company Overview
      • Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemoblast Bellows - Product Status
        • Table Hemoblast Bellows - Product Description
        • Table Biom'Up SAS - Ongoing Clinical Trials Overview
        • Table Hemoblast Bellows - Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of Hemoblast Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
    • C. R. Bard Inc Company Overview
      • C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table New Hemostat 1 - Product Status
        • Table New Hemostat 1 - Product Description
        • Table New Hemostat 2 - Product Status
        • Table New Hemostat 2 - Product Description
    • Cellphire Inc Company Overview
      • Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thromboderm - Product Status
        • Table Thromboderm - Product Description
        • Table Thrombosomes - Hemostatic Agent - Product Status
        • Table Thrombosomes - Hemostatic Agent - Product Description
    • Ceramicos Para Aplicacoes Medicas Lda Company Overview
      • Ceramicos Para Aplicacoes Medicas Lda Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceramicos Para Aplicacoes Medicas Lda Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoKi - Product Status
        • Table HemoKi - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Wound Dressing - Product Status
        • Table Hemostatic Wound Dressing - Product Description
    • Covalent Medical, Inc. (Inactive) Company Overview
      • Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CovaSTAT - Product Status
        • Table CovaSTAT - Product Description
    • Covalon Technologies Ltd Company Overview
      • Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColActive THP - Product Status
        • Table ColActive THP - Product Description
        • Table CovaStat BioActive Absorbable Hemostatic Sponge - Product Status
        • Table CovaStat BioActive Absorbable Hemostatic Sponge - Product Description
    • Cresilon Inc Company Overview
      • Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRAUMAGEL - Product Status
        • Table TRAUMAGEL - Product Description
        • Table VETIGEL - Product Status
        • Table VETIGEL - Product Description
    • CryoLife Inc Company Overview
      • CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PerClot - Product Status
        • Table PerClot - Product Description
        • Table CryoLife Inc - Ongoing Clinical Trials Overview
        • Table PerClot - Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System
    • Endomedix Incorporated Company Overview
      • Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
        • Table Surgical Hemostat - Intracranial Surgery - Product Status
        • Table Surgical Hemostat - Intracranial Surgery - Product Description
        • Table Topical Hemostat - Product Status
        • Table Topical Hemostat - Product Description
    • Entegrion Inc Company Overview
      • Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stasix - Product Status
        • Table Stasix - Product Description
    • Ethicon US LLC Company Overview
      • Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flowable thrombin - Product Status
        • Table Flowable thrombin - Product Description
        • Table Next Gen Hemostat Kit - Product Status
        • Table Next Gen Hemostat Kit - Product Description
        • Table SURGIFLO - Sterile Field Preparation - Product Status
        • Table SURGIFLO - Sterile Field Preparation - Product Description
    • Gamma Therapeutics Inc Company Overview
      • Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GammaTF - Product Status
        • Table GammaTF - Product Description
    • gel-e Inc Company Overview
      • gel-e Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table gel-e Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemogrip Spray-On Foam - Product Status
        • Table Hemogrip Spray-On Foam - Product Description
        • Table Vascular gel-e - External Wounds - Product Status
        • Table Vascular gel-e - External Wounds - Product Description
        • Table Vascular gel-e - Internal Surgical Use - Product Status
        • Table Vascular gel-e - Internal Surgical Use - Product Description
    • Haemostatix Ltd Company Overview
      • Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HaemoPlax - Product Status
        • Table HaemoPlax - Product Description
        • Table PeproStat - Product Status
        • Table PeproStat - Product Description
        • Table Haemostatix Ltd - Ongoing Clinical Trials Overview
        • Table PeproStat - A Controlled, Randomized, Multi-center, Double Blind, Phase II Study to Evaluate Efficacy and Safety of Topical PeproStat in Intraoperative Surgical Haemostasis
    • Hemostasis LLC Company Overview
      • Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ENT Hemostat - Product Status
        • Table ENT Hemostat - Product Description
        • Table Hemostatic Gel - Product Status
        • Table Hemostatic Gel - Product Description
    • KeraNetics, LLC Company Overview
      • KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratin-Based Hemostat - Product Status
        • Table Keratin-Based Hemostat - Product Description
    • LifeBond Ltd Company Overview
      • LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Absorbable Hemostats - Product Status
        • Table Absorbable Hemostats - Product Description
        • Table LifePatch Heavy - Product Status
        • Table LifePatch Heavy - Product Description
        • Table LifePatch Surgery - Product Status
        • Table LifePatch Surgery - Product Description
    • Resorba GmbH Company Overview
      • Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibiotic Hemostat - Product Status
        • Table Antibiotic Hemostat - Product Description
        • Table GENTA-COLL Resorb - Product Status
        • Table GENTA-COLL Resorb - Product Description
        • Table GENTA-FOIL Resorb - Product Status
        • Table GENTA-FOIL Resorb - Product Description
        • Table KOLLAGEN resorb - Product Status
        • Table KOLLAGEN resorb - Product Description
        • Table RESORBA CELL Fibrillar - Product Status
        • Table RESORBA CELL Fibrillar - Product Description
        • Table RESORBA CELL forte - Product Status
        • Table RESORBA CELL forte - Product Description
        • Table RESORBA CELL standard - Product Status
        • Table RESORBA CELL standard - Product Description
    • Rice University Company Overview
      • Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table KOD Hydrogel Hemostat - Product Status
        • Table KOD Hydrogel Hemostat - Product Description
    • Samyang Biopharmaceuticals Corp Company Overview
      • Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table B6102 - Hemostat - Product Status
        • Table B6102 - Hemostat - Product Description
    • Sanofi Company Overview
      • Sanofi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sanofi Pipeline Products & Ongoing Clinical Trials Overview
        • Table LeSeal - Product Status
        • Table LeSeal - Product Description
        • Table Lumagel - Product Status
        • Table Lumagel - Product Description
    • Sea Run Holdings Inc Company Overview
      • Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SEA-STAT - Product Status
        • Table SEA-STAT - Product Description
    • St Teresa Medical Inc Company Overview
      • St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SURGICLOT - Product Status
        • Table SURGICLOT - Product Description
        • Table WRAPCLOT - Product Status
        • Table WRAPCLOT - Product Description
    • The Medicines Company Company Overview
      • The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fibropad Patch - Product Status
        • Table Fibropad Patch - Product Description
    • Therus Corporation Company Overview
      • Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therus Acoustic Hemostasis System - Product Status
        • Table Therus Acoustic Hemostasis System - Product Description
    • Thrombotargets Corp Company Overview
      • Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation TT-173 - Product Status
        • Table Next Generation TT-173 - Product Description
        • Table TT-173 - Product Status
        • Table TT-173 - Product Description
    • United Health Products, Inc. Company Overview
      • United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoStyp General Surgeries Gauze - Product Status
        • Table HemoStyp General Surgeries Gauze - Product Description
        • Table HemoStyp Internal And External Procedure Gauze - Product Status
        • Table HemoStyp Internal And External Procedure Gauze - Product Description
        • Table HemoStyp Trauma Gauze - Product Status
        • Table HemoStyp Trauma Gauze - Product Description
    • University of Grenoble Alpes Company Overview
      • University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bleeding Controlling Device - Product Status
        • Table Bleeding Controlling Device - Product Description
    • Virginia Commonwealth University Company Overview
      • Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioHemostat - Product Status
        • Table BioHemostat - Product Description
    • Wound Management Technologies Inc Company Overview
      • Wound Management Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wound Management Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemaQuell - Product Status
        • Table HemaQuell - Product Description
    • Xcede Technologies Inc Company Overview
      • Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xcede - Femoral Artery - Product Status
        • Table Xcede - Femoral Artery - Product Description
        • Table Xcede - Laparoscopic Surgery - Product Status
        • Table Xcede - Laparoscopic Surgery - Product Description
        • Table Xcede - Vascular Surgery - Product Status
        • Table Xcede - Vascular Surgery - Product Description
        • Table Xcede Hemostatic Patch - Product Status
        • Table Xcede Hemostatic Patch - Product Description
  • Wound Closure Hemostats - Recent Developments
    • Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017
    • Sep 13, 2017: gel-e Expands Core Team with Regulatory, Manufacturing and Financial Talent
    • Sep 12, 2017: Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5 for Subchronic Systemic Toxicity
    • Sep 07, 2017: St. Teresa Medical Announces First Commercial Use of SURGICLOT in Auckland, New Zealand
    • Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs
    • Aug 22, 2017: United Health Products Reports Second Quarter 2017 Results
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 21, 2017: Covalon Releases Third Quarter Financial Results
    • Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results
    • Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
    • Aug 02, 2017: United Health Products Reports Profitable First Quarter ended March 31, 2017
    • Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
    • Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results
    • Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
    • Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen
    • Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang
    • Jul 27, 2017: Stryker reports second quarter 2017 results
    • Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President
    • Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
    • Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
    • Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results
    • Jul 25, 2017: Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5 Topical Gel
    • Jul 24, 2017: Ergomed completes Phase IIb study recruitment six months ahead of schedule for its innovative coagulant PeproStat
    • Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
    • Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter
    • Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results
    • Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
    • Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
    • Jun 21, 2017: PeproStat Phase IIb study passes recruitment mid-point ahead of schedule - Top line results brought forward to Q4 2017
    • Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund
    • Jun 06, 2017: Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
    • Jun 06, 2017: Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat
    • May 29, 2017: Covalon Releases Second Quarter Financial Results
    • May 26, 2017: Merit Medical Announces Appointment of New Director
    • May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
    • May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director
    • May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
    • May 03, 2017: Anika Reports First Quarter 2017 Financial Results
    • May 03, 2017: Covalon to Exhibit at the 2017 European Wound Management Association's Annual Conference
    • Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
    • Apr 28, 2017: Advanced Medical Solutions Group Reports 2016 Financial Results
    • Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017
    • Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies
    • Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017
    • Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
    • Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results
    • Apr 25, 2017: Stryker reports first quarter 2017 results
    • Apr 19, 2017: Johnson & Johnson reports Q1 2017 results
    • Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results
    • Apr 18, 2017: United Health Products to file late 2016 audited year end
    • Apr 16, 2017: Establishment of Lohmann & Rauscher Tunisie s.a.r.l.
    • Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board
    • Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
    • Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
    • Apr 11, 2017: Z-Medica Products Approved For Use In Brazil
    • Apr 05, 2017: MPP Group Announces Launch Of Dextatic Advanced Wound Care Dressing
    • Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
    • Apr 03, 2017: Baxter Unveils Design Enhancement to FLOSEAL Hemostatic Agent at AORN Meeting
    • Apr 03, 2017: Baxter Unveils Design Enhancement to TISSEEL Hemostatic Agent at AORN Meeting
    • Mar 31, 2017: B. Braun continues its sales and earnings growth
    • Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors
    • Mar 21, 2017: SeeThruEquity Issues Report on United Health Products
    • Mar 14, 2017: New Data Indicates Use of Baxter's FLOSEAL in Cardiac and Spinal Surgeries May Be Associated with Lower Hospital Costs
    • Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016
    • Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech
    • Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman
    • Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia
    • Mar 02, 2017: Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
    • Feb 28, 2017: The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results
    • Feb 22, 2017: Change in the B. Braun Management Board
    • Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
    • Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016
    • Feb 16, 2017: Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing of 510(k) for AC5
    • Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
    • Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
    • Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
    • Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 - Up 147% over Q4 2015, and 63% over 2015
    • Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
    • Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
    • Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
    • Feb 02, 2017: Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics
    • Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
    • Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
    • Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
    • Jan 30, 2017: Covalon Posts Record First Quarter Financial Results
    • Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
    • Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results
    • Jan 10, 2017: Stryker provides 2016 preliminary net sales results
    • Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care
    • Jan 03, 2017: Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth
    • Dec 08, 2016: Wound Management Technologies Welcomes J. Michael Carmena as its New CFO
    • Dec 07, 2016: Biom'up receives CE Mark Approval for HEMOBLAST Bellows, the first active hemostatic powder for management of mild to moderate intra-operative bleedings
    • Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
    • Nov 18, 2016: Dynasil and Cook Biotech Join Together to Advance Xcede Technologies Patch through First in Human Trials
    • Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
    • Nov 03, 2016: ImageIQ Selected as Imaging CRO for CryoLife's PerClot Intraoperative Hemostasis Pivotal Clinical Trial
    • Nov 01, 2016: Wound Management Technologies Reports Preliminary Financial Results For Q3 2016 Sales Up 56% over Q3 2015, and 2016 YTD Sales Up 41% over 2015 YTD Sales
    • Oct 31, 2016: Arch Therapeutics Reports AC5 Topical Hemostatic Device Successfully Stopped Bleeding in Patients on Antiplatelet Therapy in Recently Completed Clinical Study
    • Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results
    • Oct 27, 2016: Stryker reports third quarter 2016 results
    • Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results
    • Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
    • Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
    • Oct 26, 2016: The Medicines Company Reports Third-Quarter 2016 Financial Results
    • Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
    • Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors
    • Oct 24, 2016: Vascular Solutions Reports Third Quarter Results
    • Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
    • Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report